Last reviewed · How we verify
NCT07580898
Safety of MOON101 for the Treatment of Peanut Allergy
Not yet recruiting
Phase 1
What this trial tests
Phase 1 trial testing Dose A in Peanut Allergy in 40 participants. Not yet recruiting.
Timeline
7 May 2026
31 December 2027
Quick facts
| Lead sponsor | Moonlight Therapeutics, Inc. |
|---|---|
| Phase | Phase 1 |
| Status | Not yet recruiting |
| Enrollment | 40 |
| Start date | 7 May 2026 |
| Estimated completion | 31 December 2027 |
Drugs / interventions tested
- Dose A
- Dose B
- Dose C
- Dose D
- Dose E
- Placebo
Conditions studied
- Peanut Allergy — all drugs for Peanut Allergy →
Sponsor
Moonlight Therapeutics, Inc.
Who can join
Eligibility, any sex, with Peanut Allergy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07580898
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Peanut Allergy
Currently open trials in the same condition.
- NCT07349212 — UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies · Phase 1, PHASE2 · recruiting
- NCT05695261 — Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients · Phase 2 · recruiting
- NCT05503446 — Using Commonly Available Food Products To Treat Food Allergy · NA · active not recruiting
- NCT05667610 — Immune-supportive Diet and Gut Permeability in Allergic Children · NA · recruiting
- NCT06256146 — Investigating Modified Protocols of Oral Immunotherapy to Validate Efficacy and Safety · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
Data sources for this page
- Trial protocol + status: ClinicalTrials.gov NCT07580898 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Moonlight Therapeutics, Inc.
- Last refreshed: recently
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07580898.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing